Effectiveness of Flu Vaccines
DrOshidar • October 29, 2014

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Summary from The Lancet Infectious Diseases 10/17/2014 PDF

Background

No published meta-analyses have assessed efficacy and effectiveness of licensed influenza vaccines in the USA with sensitive and
highly specific diagnostic tests to confirm influenza.

Methods

We searched Medline for randomized controlled trials assessing a relative reduction in influenza risk of all circulating influenza
viruses during individual seasons after vaccination (efficacy) and observational studies meeting inclusion criteria (effectiveness).
Eligible articles were published between Jan 1, 1967, and Feb 15, 2011, and used RT-PCR or culture for confirmation of
influenza. We excluded some studies on the basis of study design and vaccine characteristics. We estimated random-effects
pooled efficacy for trivalent inactivated vaccine (TIV) and live attenuated influenza vaccine (LAIV) when data were available for
statistical analysis (eg, at least three studies that assessed comparable age groups).

Findings

We screened 5707 articles and identified 31 eligible studies (17 randomized controlled trials and 14 observational studies).
Efficacy of TIV was shown in eight (67%) of the 12 seasons analyzed in ten randomized controlled trials (pooled efficacy 59% [95%
CI 51—67] in adults aged 18—65 years). No such trials met inclusion criteria for children aged 2—17 years or adults aged 65 years
or older. Efficacy of LAIV was shown in nine (75%) of the 12 seasons analyzed in ten randomized controlled trials (pooled efficacy
83% [69—91]) in children aged 6 months to 7 years. No such trials met inclusion criteria for children aged 8—17 years. Vaccine
effectiveness was variable for seasonal influenza: six (35%) of 17 analyses in nine studies showed significant protection against
medically attended influenza in the outpatient or inpatient setting. Median monovalent pandemic H1N1 vaccine effectiveness in
five observational studies was 69% (range 60—93).

Interpretation

Influenza vaccines can provide moderate protection against virologically confirmed influenza, but such protection is greatly
reduced or absent in some seasons. Evidence for protection in adults aged 65 years or older is lacking. LAIVs consistently show
highest efficacy in young children (aged 6 months to 7 years). New vaccines with improved clinical efficacy and effectiveness
are needed to further reduce influenza-related morbidity and mortality.


Credits : Alfred P Sloan Foundation, Prof Michael T Osterholm PhD, Nicholas S Kelley PhD, Prof Alfred Sommer MD, Edward A Belongia MD

By Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP March 13, 2024
https://www.functionalmedicineuniversity.com/public/2000.cfm ** Feel free to use this article on your website. Compliments from Functional Medicine University . ** Read my past articles: http://www.functionalmedicineuniversity.com/public/department88.cfm ===================== View Rick Bramos Fitness YouTube Channel https://www.youtube.com/channel/UC_x4I27Z0DfYkfcroXxAhcA/videos Here is Rick's New Video of the Week: https://www.youtube.com/watch?v=W__EwtXJkyY Rick is now offering phone consultations for those wanting to lose weight or simply to improve their fitness. Rick can be reached at 2days2fitness@gmail.com for more details. ===================== ATTENTION DOCTORS AND ALL HEALTHCARE PRACTITIONERS Tell your friends and colleagues about Clinical Rounds. This is a great introduction to the field of functional medicine. Here is the webpage to subscribe: http://www.clinicalrounds.com Take care, Ron P.S. Please visit our facebook page and "Like It" Of course if you really like it. :) http://www.facebook.com/pages/Functional-Medicine-University/161486170671332
By Anthony Lembo, MD, Harvard Health Publishing July 7, 2023
Irritable bowel syndrome (IBS) is a chronic gut-brain disorder that can cause a variety of uncomfortable gastrointestinal symptoms including abdominal pain and diarrhea, constipation, or a mix of the two. IBS can reduce quality of life, often results in missed school or work, and can have a substantial economic impact.
By CHRISTINE LIN ET AL., THE CONVERSATION June 30, 2023
Opioids are the one of the most prescribed pain-relief for people with low back and neck pain. In Australia, around 40 percent of people with low back and neck pain who present to their GP and 70 percent of people with low back pain who visit a hospital emergency department are prescribed opioids such as oxycodone. But our new study, published today in the Lancet medical journal, found opioids do not relieve "acute" low back or neck pain (lasting up to 12 weeks) and can result in worse pain. Prescribing opioids for low back and neck pain can also cause harms ranging from common side effects – such as nausea, constipation and dizziness – to misuse, dependency, poisoning, and death. Our findings show opioids should not be recommended for acute low back pain or neck pain. A change in prescribing for low back pain and neck pain is urgently needed in Australia and globally to reduce opioid-related harms. Comparing opioids to a placebo In our trial, we randomly allocated 347 people with acute low back pain and neck pain to take either an opioid (oxycodone plus naloxone) or placebo (a tablet that looked the same but had no active ingredients).  Oxycodone is an opioid pain medicine which can be given orally. Naloxone, an opioid-reversal drug, reduces the severity of constipation while not disrupting the pain relieving effects of oxycodone. Participants took the opioid or placebo for a maximum of six weeks. People in the both groups also received education and advice from their treating doctor. This could be, for example, advice on returning to their normal activities and avoiding bed rest. We assessed their outcomes over a one-year period. What did we find? After six weeks of treatment, taking opioids did not result in better pain relief compared to the placebo. Nor were there benefits to other outcomes such as physical function, quality of life, recovery time, or work absenteeism. More people in the group treated with opioids experienced nausea, constipation, and dizziness than in the placebo group. Results at one year highlight the potential long-term harm of opioids even with short-term use. Compared to the placebo group, people in the opioid group experienced slightly worse pain, and reported a higher risk of opioid misuse (problems with their thinking, mood or behavior, or using opioids differently from how the medicines were prescribed). More people in the opioid group reported pain at one year: 66 people compared to 50 in the placebo group. What will this mean for opioid prescribing? In recent years, international low back pain guidelines have shifted the focus of treatment from drug to non-drug treatment due to evidence of limited treatment benefits and concern of medication-related harm. For acute low back pain, guidelines recommend patient education and advice, and if required, anti-inflammatory pain medicines such as ibuprofen. Opioids are recommended only when other treatments haven't worked or aren't appropriate. Guidelines for neck pain similarly discourage the use of opioids. Our latest research clearly demonstrates the benefits of opioids do not outweigh possible harms in people with acute low back pain and neck pain. Instead of advising opioid use for these conditions in selected circumstances, opioids should be discouraged without qualification. Change is possible Complex problems such as opioid use need smart solutions, and another study we recently conducted provides convincing data opioid prescribing can be successfully reduced. The study involved four hospital emergency departments, 269 clinicians and 4,625 patients with low back pain. The intervention comprised of: clinician education about evidence-based management of low back pain patient education using posters and handouts to highlight the benefits and harms of opioids providing heat packs and anti-inflammatory pain medicines as alternative pain-management treatments fast-tracking referrals to outpatient clinics to avoid long waiting lists audits and feedback to clinicians on information about opioid prescribing rates. This intervention reduced opioid prescribing from 63 percent to 51 percent of low back pain presentations. The reduction was sustained for 30 months. Key to this successful approach is that we worked with clinicians to develop suitable pain-management treatments without opioids that were feasible in their setting. More work is needed to evaluate this and other interventions aimed at reducing opioid prescribing in other settings including GP clinics. A nuanced approach is often necessary to avoid causing unintended consequences in reducing opioid use. If people with low back pain or neck pain are using opioids, especially at higher doses over an extended period of time, it's important they seek advice from their doctor or pharmacist before stopping these medicines to avoid unwanted effects when the medicines are abruptly stopped. Our research provides compelling evidence opioids have a limited role in the management of acute low back and neck pain. The challenge is getting this new information to clinicians and the general public, and to implement this evidence into practice.
By Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP May 8, 2023
The Amazing Benefits of Olive Oil (Be Aware of Fake Olive Oil) | Functional Medicine University - The Leader in Online Training in Functional Diagnostic Medicine
By Advanced Back and Neck Care June 17, 2022
by Holly Lookabaugh-Deur, PT, DSc, GCS Undetected Post Concussion Symptoms In Older Adults Over the years, I have treated many older patients following a fall or fracture, and a recent case is a prime inspiration for this article. The importance of treating the WHOLE person and advocating for yourself and those you love is so very important. My story is about an 84-year-old woman who lives alone, fell changing a light bulb, and fractured her hip. Following surgery, she struggled ...
Medicine Tablets and Capsules — Lumberton, NJ — Advanced Back And Neck Care
By Matthew Solan June 1, 2022
Acetaminophen (Tylenol) is often recommended for pain relief in people with high blood pressure because most other options can raise blood pressure. A 2022 study suggests acetaminophen might sometimes have a similar effect.
Show More